The CYP2C19*17 variant is not associated with an increased response to clopidogrel, but it increases the risk for the development of carotid artery stenosis.

Rakicević, Ljiljana; Novković, Mirjana; Backović, Dragana; Strugarević, Evgenija; Kovac, Mirjana; Kusic-Tisma,  Jelena; Radojkovic, Dragica

Results

eNauka > Results > The CYP2C19*17 variant is not associated with an increased response to clopidogrel, but it increases the risk for the development of carotid artery stenosis.

Title:	The CYP2C19*17 variant is not associated with an increased response to clopidogrel, but it increases the risk for the development of carotid artery stenosis.
Authors:	Rakicević, Ljiljana ; Novković, Mirjana ; Backović, Dragana; Strugarević, Evgenija; Kovac, Mirjana; Kusic-Tisma, Jelena ; Radojkovic, Dragica
Issue Date:	2021
Publication:	7th European Section and 8th North American Section Meeting of the International Academy of Cardiovascular Sciences (IACS) - Cardioprotection and Cardiometabolic Diseases: From Bench to Bedside, Banja Luka, 20-23 September 2021
Type:	Conference Paper
URI:	https://enauka.gov.rs/handle/123456789/905659
URL:	http://www.iacs.sav.sk/IACS2021.pdf
Metadata source:	(Preuzeto iz ORCID-a) Rakićević, Ljiljana
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM